Health and Fitness Health and Fitness
Fri, November 4, 2011
[ Fri, Nov 04th 2011 ] - Market Wire
KCI e consrcio dirigidos pela Apax Partners anunciam concluso das conversaes sobre gesto executiva
[ Fri, Nov 04th 2011 ] - Market Wire
Ardea Biosciences Reports Recent Accomplishments, .. g Events and Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected
[ Fri, Nov 04th 2011 ] - Market Wire
Cancer Treatments From Dendreon and Cell Therapeutics May Not Be as Lucrative as Hoped
[ Fri, Nov 04th 2011 ] - Market Wire
Equity Research on Raptor Pharmaceuticals Corp. a .. Mixed Results for Diagnostic Substances Industry
[ Fri, Nov 04th 2011 ] - Market Wire
For The Earth Corporation Grows Globally
[ Fri, Nov 04th 2011 ] - Market Wire
Novadaq Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
[ Fri, Nov 04th 2011 ] - Market Wire
Quest Diagnostics anuncia el lanzamiento del test .. Direct para gripe y virus respiratorios en Europa
Thu, November 3, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
Galapagos wins 2011 Scrip Award for Biotech Company of the Year
[ Thu, Nov 03rd 2011 ] - Market Wire
Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China
[ Thu, Nov 03rd 2011 ] - Market Wire
Humana Inc. to Present at the Credit Suisse 2011 Healthcare Conference
[ Thu, Nov 03rd 2011 ] - Market Wire
Sirona Biochem Announces New Grant of Stock Options
[ Thu, Nov 03rd 2011 ] - Market Wire
MSA Declares Fourth Quarter Dividend
[ Thu, Nov 03rd 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results
[ Thu, Nov 03rd 2011 ] - Market Wire
AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments
[ Thu, Nov 03rd 2011 ] - Market Wire
BioElectronics' Study on Postoperative Pain Reduc .. ublished in the Aesthetic Plastic Surgery Journal
[ Thu, Nov 03rd 2011 ] - Market Wire
SpectraScience to Hold Business Update Conference Call on November 10, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
MethylGene Reports Third Quarter 2011 Financial Results and Provides Clinical Update
[ Thu, Nov 03rd 2011 ] - Market Wire
Dynavax Prices Public Offering of Common Stock
[ Thu, Nov 03rd 2011 ] - Market Wire
Celsion Corporation to Hold Third Quarter 2011 Fi .. ts Conference Call on Thursday, November 10, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
SecureAlert, Inc. and Commonwealth of Puerto Rico .. Violence With Focus on Family Safety and Real-Tim
[ Thu, Nov 03rd 2011 ] - Market Wire
FONAR Reports Error in Reports Regarding Its Common Stock
[ Thu, Nov 03rd 2011 ] - Market Wire
Medivation and Astellas Announce Positive Surviva .. of Phase 3 AFFIRM Trial of MDV3100 in Men With Ad
[ Thu, Nov 03rd 2011 ] - Market Wire
Kraig Biocraft Laboratories, Inc. Signs Spider Si .. cense Agreement With the University of Notre Dame
Wed, November 2, 2011
[ Wed, Nov 02nd 2011 ] - Market Wire
ING 3Q11 underlying net profit increases to EUR 1,285 million
[ Wed, Nov 02nd 2011 ] - Market Wire
Quidel to Present at Credit Suisse 2011 Health Care Conference
[ Wed, Nov 02nd 2011 ] - Market Wire
Bellicum Announces Publication in The New England .. ating Complete Reversal of Serious Immune Conditi
[ Wed, Nov 02nd 2011 ] - Market Wire
Nuvo Research Announces 2011 Third Quarter Results
[ Wed, Nov 02nd 2011 ] - Market Wire
Cadence Pharmaceuticals' CEO Ted Schroeder to Pre .. Suisse Healthcare Conference on November 9, 2011

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Credit Suisse Healthcare Conference on November 9, 2011


Published on 2011-11-02 18:20:26 - Market Wire
  Print publication without navigation


Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Credit Suisse Healthcare... -- SAN DIEGO, Nov. 2, 2011 /PRNewswire/ --

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Credit Suisse Healthcare Conference on November 9, 2011

[ ]

SAN DIEGO, Nov. 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, November 9, 2011 at 1:30pm Mountain Time (3:30pm Eastern Time) during the Credit Suisse Healthcare Conference at the Arizona Biltmore Hotel in Phoenix.

.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit [ www.cadencepharm.com ].

Contacts:

William R. LaRue


SVP & Chief Financial Officer


Cadence Pharmaceuticals, Inc.


858-436-1400



SOURCE Cadence Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.cadencepharm.com ]

Contributing Sources